Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**"Pain perception pathways"** refer collectively to the complex anatomical and molecular systems responsible for detecting harmful stimuli and transmitting this information from peripheral tissues through the spinal cord to various brain regions where it is processed as conscious experience. These include primary afferent nociceptors that detect tissue damage via specialized ion channels such as transient receptor potential channels; neurotransmitters like glutamate and substance P that relay signals at synapses; ascending tracts such as the spinothalamic tract that carry information centrally; and descending modulatory systems involving endogenous opioids and monoamines that can amplify or suppress incoming signals. The system is highly integrated with emotional centers in the brain—including limbic structures—and is subject to neuroplastic changes in chronic pain states. Importantly, "pain perception pathways" do not represent a discrete therapeutic target but rather encompass multiple distinct molecular targets used in analgesic drug development. > “The primary afferent neurons involved in detection and transmission of pain are referred to as nociceptors... They transduce local ‘noxious’ information into action potentials via cell membranous ion channels... Once activated they transduce physical or chemical stimuli into transient action potentials via modulation of ion entry.” > “There are four major processes: transduction, transmission, modulation, and perception... Perception is a complex function... integrating many sensory messages into a coherent whole.” > “This review delves into nociceptive signaling pathways... how these signals are processed by critical elements such as ion channels, receptors, neurotransmitters...” **Summary judgment:** “Pain perception pathways” is **not** an individual molecule/receptor/therapeutic target but describes an interconnected network comprising numerous validated drug targets. For structured data purposes it should be flagged as incorrect/ineligible under standard definitions requiring specificity at gene/protein/molecule level.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pain perception pathways.